A placebo effect is the tendency of any medication or treatment, even an inert or ineffective one, to exhibit results simply because the recipient believes that it will work.
Placebo effect may also refer to:
Ring may refer to:
James may refer to:
A Peeping Tom is a nickname for a male voyeur, from the character Peeping Tom, who spied on the Lady Godiva's naked ride.
A placebo is a substance or treatment which is designed to have no therapeutic value. Common placebos include inert tablets, inert injections, sham surgery, and other procedures.
Tempest is a synonym for a storm.
Placebo are a British alternative rock band, formed in London in 1994 by vocalist–guitarist Brian Molko and bassist–guitarist Stefan Olsdal, and in late 1994 Robert Schultzberg joined as drummer. Molko was born in Belgium and Olsdal and Schultzberg in Sweden; Molko and Olsdal grew up in Luxembourg before separately relocating to London and becoming British citizens. Schultzberg left the band in 1996 shortly after the release of the band's eponymous debut album due to conflicts with Molko, and was replaced the same year by Steve Hewitt.
A placebo is a substance or treatment without intrinsic therapeutic value but administered as if it were a therapy, whether in medical treatment or in clinical trials.
A nocebo effect is said to occur when negative expectations of the patient regarding a treatment cause the treatment to have a more negative effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can experience that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. The nocebo effect is also said to occur in someone who falls ill owing to the erroneous belief that they were exposed to a toxin, e.g. a physical phenomenon they believe is harmful, such as EM radiation.
Observer effect, observer bias, observation effect, or observation bias may refer to a number of concepts, some of them closely related:
Spoiler or Spoilers may refer to:
A scientific control is an experiment or observation designed to minimize the effects of variables other than the independent variable. This increases the reliability of the results, often through a comparison between control measurements and the other measurements. Scientific controls are a part of the scientific method.
Haunted or The Haunted may refer to:
Sham may refer to:
Thirteen or 13 may refer to:
Gepirone, sold under the brand name Exxua, is a medication used for the treatment of major depressive disorder. It is taken orally.
Esketamine, sold under the brand names Spravato and Ketanest among others, is the S(+) enantiomer of ketamine. It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine.
Placebo-controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham "placebo" treatment which is specifically designed to have no real effect. Placebos are most commonly used in blinded trials, where subjects do not know whether they are receiving real or placebo treatment. Often, there is also a further "natural history" group that does not receive any treatment at all.
Never Let Me Go may refer to:
Lemborexant, sold under the brand name Dayvigo, is an orexin antagonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset and/or maintenance in adults. The medication is taken by mouth.
Ulotaront is an investigational antipsychotic that is undergoing clinical trials for the treatment of schizophrenia and Parkinson's disease psychosis. The medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals using PsychoGenics' behavior and AI-based phenotypic drug discovery platform, SmartCube. Ulotaront is in Phase III of clinical development.